Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs rabeprazole for Helicobacter pylori eradication
ChiCTR2100052576Phase 4Recruiting
- Sponsor
- Jinshan Hospital of the First Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan and rabeprazole in Helicobacter pylori infection and chronic gastritis (3 arms), sponsored by Jinshan Hospital of the First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Eradication rates of Helicobacter pylori. Started Dec 2021; status: recruiting.
02
Drugs
vonoprazanrabeprazole
03
Conditions
Helicobacter pylori infectionchronic gastritis
Beyond the preview
Go deeper on ChiCTR2100052576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052576.